Daktacort 2%/1% w/w cream

Daktacort is a well-known medicinal cream used to treat skin conditions like athlete's foot and sweat rash where inflammation is present. It combines an antifungal agent, miconazole nitrate, with a mild corticosteroid, hydrocortisone. The brand is closely associated with the Janssen pharmaceutical legacy, which has long been a leader in fungal research and specialized dermatological treatments.

Originally developed by Janssen Pharmaceutica in Belgium, the brand is now part of the extensive healthcare portfolio of Johnson & Johnson. While the packaging shown is for the UK market (distributed by Janssen-Cilag Ltd in High Wycombe), the production of these pharmaceuticals often occurs across several global manufacturing sites to ensure supply for international markets. As of 2026, the brand remains under the ultimate ownership of Kenvue (the spun-off consumer health division of Johnson & Johnson) in many regions, while remaining under the core Janssen/Johnson & Johnson medical umbrella for specific prescription formulations.